Tradestie Institutional Equity Comparison Engine

UFPT vs ENOV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

UFPT Overall Edge

UFPT Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UFP Technologies Inc (UFPT) driven by superior Growth & Margin, Options & Structure while ENOV counters with relative strength in Valuation, Momentum & Technical. Fundamentally, UFPT trades at 24.7x Forward P/E with 15.4% operating margin (+11.6% YoY revenue) versus ENOV at 8.1x Forward P/E and 4.0% operating margin (+1.8% YoY). In options structure, UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro) against ENOV sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ENOV
UFPT 24.7x vs ENOV 8.1x Fwd P/E
Growth & Margin Winner UFPT
Op Margin 15.4% vs 4.0% ยท YoY +11.6% vs +1.8%
Momentum & Technical Winner ENOV
1Y +27.4% vs -9.6% ยท 52W Pos 74% vs 74%
Options & Structure Winner UFPT
UNCLASSIFIED (3rd %ile IV) vs UNCLASSIFIED (43rd %ile IV)
UFPT NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap $2.4B
1M Return +2.36%
1Y Return +27.42%
Forward P/E 24.7x
Unified AI Score
42.6 / 100 HOLD
Tech 25.0 Fund 37.0 Flow 50.0 Mom 40.0
ENOV NYSE
Enovis Corporation
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$27.92
+0.87% 1D
Market Cap $1.6B
1M Return +42.52%
1Y Return -9.56%
Forward P/E 8.1x
Unified AI Score
27.7 / 100 SELL
Tech 50.0 Fund 29.0 Flow 50.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UFPT +27.42% ENOV -9.56% Spread: +36.98 pp (UFPT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UFPT TTM Op. Margin: 15.4% ENOV TTM Op. Margin: 4.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UFPT vs ENOV. Trailing 12-month operating profitability (UFPT 15.4% vs ENOV 4.0%) and valuation multiples (UFPT 24.7x vs ENOV 8.1x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UFPT (7) vs ENOV (2)
Institutional Metric UFPT ENOV Criterion Row Winner
Market Capitalization Scale $2.4B $1.6B Larger Scale UFPT
Trailing P/E Ratio Valuation 31.2x 7.7x Lower Multiple ENOV
Forward P/E Ratio Valuation 24.7x 8.1x Lower Multiple ENOV
Revenue Growth (YoY) Growth +11.6% +1.8% Higher Growth UFPT
Operating Margin (TTM) Profitability 15.4% 4.0% Higher Margin UFPT
Net Profit Margin Profitability 11.8% -22.9% Higher Margin UFPT
Return on Equity (ROE) Capital Efficiency 17.2% -29.9% Higher ROE UFPT
52-Week Range Position Momentum 74% ($174โ€“$342) 74% ($17โ€“$32) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.64ฮฒ ยท 77% Vol 0.78ฮฒ ยท 101% Vol Lower Realized Risk UFPT
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 27.7 / 100 (SELL) Higher Composite UFPT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UFPT vs ENOV Buy Guide
UFPT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live UFPT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ENOV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENOV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UFPT nor ENOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.